{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:30:30Z","timestamp":1791901830538,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02803-2","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T14:02:31Z","timestamp":1705932151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case\u2013control study in the All of Us Research Program"],"prefix":"10.1007","volume":"316","author":[{"given":"Kanika","family":"Kamal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Theodosakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"issue":"44","key":"2803_CR1","doi-asserted-by":"publisher","first-page":"e22983","DOI":"10.1097\/MD.0000000000022983","volume":"99","author":"F Guo","year":"2020","unstructured":"Guo F, Yu Q, Liu Z et al (2020) Evaluation of life quality, anxiety, and depression in patients with skin diseases. Medicine 99(44):e22983\u2013e22983. https:\/\/doi.org\/10.1097\/MD.0000000000022983","journal-title":"Medicine"},{"issue":"2","key":"2803_CR2","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1111\/jdv.15987","volume":"34","author":"G Dabas","year":"2020","unstructured":"Dabas G, Vinay K, Parsad D, Kumar A, Kumaran MS (2020) Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol 34(2):392\u2013399. https:\/\/doi.org\/10.1111\/jdv.15987","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2803_CR3","doi-asserted-by":"publisher","first-page":"114720","DOI":"10.1016\/j.psychres.2022.114720","volume":"315","author":"O Jegede","year":"2022","unstructured":"Jegede O, Rhee TG, Stefanovics EA, Zhou B, Rosenheck RA (2022) Rates and correlates of dual diagnosis among adults with psychiatric and substance use disorders in a nationally representative US sample. Psychiatry Res 315:114720. https:\/\/doi.org\/10.1016\/j.psychres.2022.114720","journal-title":"Psychiatry Res"},{"issue":"6","key":"2803_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jaad.2022.09.015","volume":"87","author":"R Fan","year":"2022","unstructured":"Fan R, Leasure AC, Damsky W, Cohen JM (2022) Alcohol use disorder among adults with atopic dermatitis: a case\u2013control study in the All of Us research program. J Am Acad Dermatol 87(6):1378\u20131380. https:\/\/doi.org\/10.1016\/j.jaad.2022.09.015","journal-title":"J Am Acad Dermatol"},{"key":"2803_CR5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3328","author":"MR Nock","year":"2023","unstructured":"Nock MR, Kamal K, Zampella JG, Roberson ML, Cohen JM, Barbieri JS (2023) Barriers to care among sexual and gender minority individuals with chronic inflammatory skin diseases in the US. JAMA Dermatol. https:\/\/doi.org\/10.1001\/jamadermatol.2023.3328. (Published online September 27, 2023)","journal-title":"JAMA Dermatol"},{"key":"2803_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","volume":"58","author":"DP MacKinnon","year":"2007","unstructured":"MacKinnon DP, Fairchild AJ, Fritz MS (2007) Mediation analysis. Annu Rev Psychol 58:593\u2013614. https:\/\/doi.org\/10.1146\/annurev.psych.58.110405.085542","journal-title":"Annu Rev Psychol"},{"issue":"11","key":"2803_CR7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1001\/jama.2021.14075","volume":"326","author":"H Lee","year":"2021","unstructured":"Lee H, Cashin AG, Lamb SE et al (2021) A guideline for reporting mediation analyses of randomized trials and observational studies. JAMA 326(11):1045. https:\/\/doi.org\/10.1001\/jama.2021.14075","journal-title":"JAMA"},{"issue":"7","key":"2803_CR8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/jdv.17110","volume":"35","author":"N Germain","year":"2021","unstructured":"Germain N, Augustin M, Fran\u00e7ois C et al (2021) Stigma in visible skin diseases\u2014a literature review and development of a conceptual model. J Eur Acad Dermatol Venereol 35(7):1493\u20131504. https:\/\/doi.org\/10.1111\/jdv.17110","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2803_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15230","author":"J Toy","year":"2022","unstructured":"Toy J, Wan V, Lee DG, Liu C, Fleming P, Lynde C (2022) Perspectives and knowledge of acne vulgaris among young adolescents. Pediatr Dermatol. https:\/\/doi.org\/10.1111\/pde.15230. (Published online December 28, 2022)","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"2803_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jama.2018.11406","volume":"320","author":"HR Kranzler","year":"2018","unstructured":"Kranzler HR, Soyka M (2018) Diagnosis and pharmacotherapy of alcohol use disorder. JAMA 320(8):815. https:\/\/doi.org\/10.1001\/jama.2018.11406","journal-title":"JAMA"},{"issue":"13","key":"2803_CR11","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijerph18136709","volume":"18","author":"T Montero-Vilchez","year":"2021","unstructured":"Montero-Vilchez T, Diaz-Calvillo P, Rodriguez-Pozo JA et al (2021) The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis. Int J Environ Res Public Health 18(13):6709. https:\/\/doi.org\/10.3390\/ijerph18136709","journal-title":"Int J Environ Res Public Health"},{"key":"2803_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107825","volume":"208","author":"KM McGrew","year":"2020","unstructured":"McGrew KM, Homco JB, Garwe T et al (2020) Validity of International Classification of Diseases codes in identifying illicit drug use target conditions using medical record data as a reference standard: a systematic review. Drug Alcohol Depend 208:107825. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107825","journal-title":"Drug Alcohol Depend"},{"key":"2803_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108583","volume":"221","author":"P Lagisetty","year":"2021","unstructured":"Lagisetty P, Garpestad C, Larkin A et al (2021) Identifying individuals with opioid use disorder: validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse. Drug Alcohol Depend 221:108583. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108583","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"2803_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/jdv.18564","volume":"37","author":"J Wan","year":"2023","unstructured":"Wan J, Shin DB, Syed MN, Abuabara K, Lemeshow AR, Gelfand JM (2023) Atopic dermatitis and risk of major neuropsychiatric disorders in children: a population-based cohort study. J Eur Acad Dermatol Venereol 37(1):114\u2013122. https:\/\/doi.org\/10.1111\/jdv.18564","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2803_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jdin.2020.10.010","volume":"2","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Mostaghimi A, Noe MH, Margolis DJ, Gelfand JM (2020) Use of primary care services among patients with chronic skin disease seen by dermatologists. JAAD Int 2:31\u201336. https:\/\/doi.org\/10.1016\/j.jdin.2020.10.010","journal-title":"JAAD Int"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02803-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02803-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T16:04:07Z","timestamp":1707753847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02803-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["2803"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02803-2","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"4 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.M. receives consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, Abbvie, Equillium, and Boehringer Ingelheim. A.M. also owns equity in hims, Fig.\u00a01, Acom, Seebe. He receives licensing fees and royalties from Pfizer, Concert, and Lilly. He serves on the medical advisory board for hims, Fig.\u00a01, and Digital Diagnostics. A.M. oversees clinical trials for Lilly and Concert. J.M.C. serves on a data and safety moniroting board (DSMB) for Advarra. J.S.B. is an associate editor for JAMA Dermatology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was deemed exempt by the Yale School of Medicine Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable, as research has been deemed as non-human subject research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}],"article-number":"79"}}